115 related articles for article (PubMed ID: 26847870)
21. TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
Green T; Chen X; Ryan S; Asch AS; Ruiz-Echevarría MJ
Prostate; 2013 Oct; 73(14):1561-75. PubMed ID: 23824605
[TBL] [Abstract][Full Text] [Related]
22. Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
Cha YJ; Kim DH; Jung WH; Koo JS
Int J Clin Exp Pathol; 2014; 7(11):7824-33. PubMed ID: 25550822
[TBL] [Abstract][Full Text] [Related]
23. Metabolomic signatures of aggressive prostate cancer.
McDunn JE; Li Z; Adam KP; Neri BP; Wolfert RL; Milburn MV; Lotan Y; Wheeler TM
Prostate; 2013 Oct; 73(14):1547-60. PubMed ID: 23824564
[TBL] [Abstract][Full Text] [Related]
24. Prostate tumor attenuation in the nu/nu murine model due to anti-sarcosine antibodies in folate-targeted liposomes.
Heger Z; Polanska H; Merlos Rodrigo MA; Guran R; Kulich P; Kopel P; Masarik M; Eckschlager T; Stiborova M; Kizek R; Adam V
Sci Rep; 2016 Sep; 6():33379. PubMed ID: 27646588
[TBL] [Abstract][Full Text] [Related]
25. Glycine/glycine N-methyltransferase/sarcosine axis mediates benzene-induced hematotoxicity.
Zhang W; Guo X; Ren J; Chen Y; Wang J; Gao A
Toxicol Appl Pharmacol; 2021 Oct; 428():115682. PubMed ID: 34418406
[TBL] [Abstract][Full Text] [Related]
26. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.
Thomas LN; Merrimen J; Bell DG; Rendon R; Goffin V; Too CK
Prostate; 2014 May; 74(7):732-42. PubMed ID: 24615730
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine.
Strmiska V; Michalek P; Eckschlager T; Stiborova M; Adam V; Krizkova S; Heger Z
Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):248-258. PubMed ID: 30708041
[TBL] [Abstract][Full Text] [Related]
28. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
29. Characterization of osmolyte betaine synthesizing sarcosine dimethylglycine N-methyltransferase from Methanohalophilus portucalensis.
Chen SY; Lai MC; Lai SJ; Lee YC
Arch Microbiol; 2009 Oct; 191(10):735-43. PubMed ID: 19693490
[TBL] [Abstract][Full Text] [Related]
30. The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B.
Ren K; Gou X; Xiao M; Wang M; Liu C; Tang Z; He W
Prostate; 2013 Sep; 73(13):1462-9. PubMed ID: 23813671
[TBL] [Abstract][Full Text] [Related]
31. A novel tumor suppressor function of glycine N-methyltransferase is independent of its catalytic activity but requires nuclear localization.
DebRoy S; Kramarenko II; Ghose S; Oleinik NV; Krupenko SA; Krupenko NI
PLoS One; 2013; 8(7):e70062. PubMed ID: 23936142
[TBL] [Abstract][Full Text] [Related]
32. Expression of proton-coupled oligopeptide transporter (POTs) in prostate of mice and patients with benign prostatic hyperplasia (BPH) and prostate cancer (PCa).
Sun D; Tan F; Fang D; Wang Y; Zeng S; Jiang H
Prostate; 2013 Feb; 73(3):287-95. PubMed ID: 22887093
[TBL] [Abstract][Full Text] [Related]
33. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
34. Effects of substrate and potassium on the betaine-synthesizing enzyme glycine sarcosine dimethylglycine N-methyltransferase from a halophilic methanoarchaeon Methanohalophilus portucalensis.
Lai MC; Wang CC; Chuang MJ; Wu YC; Lee YC
Res Microbiol; 2006 Dec; 157(10):948-55. PubMed ID: 17098399
[TBL] [Abstract][Full Text] [Related]
35. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.
Jentzmik F; Stephan C; Lein M; Miller K; Kamlage B; Bethan B; Kristiansen G; Jung K
J Urol; 2011 Feb; 185(2):706-11. PubMed ID: 21168877
[TBL] [Abstract][Full Text] [Related]
36. Genetic factors regulating inflammation and DNA methylation associated with prostate cancer.
Ianni M; Porcellini E; Carbone I; Potenzoni M; Pieri AM; Pastizzaro CD; Benecchi L; Licastro F
Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):56-61. PubMed ID: 22850906
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study.
Chen M; Huang YL; Huang YC; Shui IM; Giovannucci E; Chen YC; Chen YM
PLoS One; 2014; 9(5):e94683. PubMed ID: 24800880
[TBL] [Abstract][Full Text] [Related]
38. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
39. Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells.
Petersen LF; Brockton NT; Bakkar A; Liu S; Wen J; Weljie AM; Bismar TA
BJU Int; 2012 Mar; 109(5):788-95. PubMed ID: 21771248
[TBL] [Abstract][Full Text] [Related]
40. Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine.
Ferro M; Lucarelli G; Bruzzese D; Perdonà S; Mazzarella C; Perruolo G; Marino A; Cosimato V; Giorgio E; Tagliamonte V; Bottero D; De Cobelli O; Terracciano D
Anticancer Res; 2015 Feb; 35(2):1017-23. PubMed ID: 25667489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
